NanoViricides Inc. (NNVC)

[ZincFinger]

Your conclusion that BP not having tried to buy out NNVC AT THIS STATE (hasn't even STARTED the data gathering toxicology study)shows a total lack of awareness of how Big Pharma behaves despite your contention otherwise.

BP is, as you say, risk averse. Precisely because of that, they do not buy out early stage drugs and usually buy in Phase III, occasionally in Phase II. They are just as lousy at picking winners early on as they are at creating new concept drugs.

I have never heard of a BP buying out as soon as after IND approval (not even as soon as Phase I although that is at least conceivable), much less before data gathering part of toxicology is even begun.

Your suggestion that BP not buying at this point is a red flag is "so bad it is not even wrong" as Pauli would say.